Ondansetron Injection BP (4 mg/2 mL, 8mg/4mL)
Product Description
Kaisha Lifesciences Pvt. Ltd
-
Country/Region:India
-
On CPHI since:2019
-
Employees:25 - 49
Company types
Primary activities
Kaisha Lifesciences Pvt. Ltd
-
Country/Region:India
-
On CPHI since:2019
-
Employees:25 - 49
Company types
Primary activities
More Products from Kaisha Lifesciences Pvt. Ltd (3)
-
Product Oxytocin Injection BP (5 IU/0.5mL, 5 IU/1mL, 10 IU/1mL)
CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 1 mL USP Type 1 Glass Ampoule Pack Size - 5 Ampoules packed in Blister, 15 such Blisters packed in Monocarton with Insert (75 Ampoules in Monocarton) Shelf Life - 24 months (Extended Stability Data available till 36 Months) Process Ty... -
Product Pantoprazole for Injection BP 40 mg/vial (Unit Lyophilized)
CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 10 mL USP Type 1 Glass Vial Pack Size - 1 Vial packed in Monocarton with Insert Shelf Life - 24 months (Extended Stability Data available till 30 Months) Process Type - Aseptically Sterilized GMP Approval - EU Hungary, ANIVSA Brazil -
Product Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL)
Enoxaparin injection is an anticoagulant primarily indicated for the prevention of deep vein thrombosis (DVT), which can lead to life-threatening pulmonary embolisms (blood clots in the lungs).
Kaisha Lifesciences Pvt. Ltd resources (4)
-
Brochure Pipeline Products with Dossier Readiness Timelines (2027)
General Category SVP's in the Pipeline for 2027 -
Brochure Kaisha Lifesciences - Presentation and Current Portfolio
• CDMO / CMO for Injectable Finished Formulations • Ready CTD Dossiers with Zone IVb Stability • New Product Development
-
Brochure Sovereign Pharma - Presentation
• 100% Contract Manufacturing Facility for SVP's. • We supply over 350 million injections globally. • Approved by EU, PIC/s, UKMHRA -
Brochure KAIVEXIN (Enoxaparin PFS with Sycure AD)
The Efficacious Enoxaparin with Sycure AD AdvantagePrevents misuse of PFSIndividual always receives the right dosage of EnoxaparinHelps to reduce human errorUSDMF grade APIEase of administration